Systemic (Rheumatic)

Polymyalgia Rheumatica (PMR)

류마티스성 다발근통

Inflammatory disease with bilateral shoulder/pelvic girdle pain, morning stiffness, and elevated ESR

How common
1–2 per 1,000 adults >50
Typical age
Age >50, average 70s

What is it?

Immune-mediated synovitis and bursitis around shoulder/pelvic girdles; muscles themselves are spared (strength preserved).

Commonly affected: Shoulder, neck, and pelvic girdle synovia and bursae

How it develops

  1. Age-Related Immune ShiftIncreased IL-6 and inflammatory cytokines in elderly
  2. Proximal Synovitis/BursitisSubacromial, subdeltoid, trochanteric bursitis
  3. Systemic InflammationMarked ESR/CRP elevation
  4. Possible GCA Overlap10–20% develop giant cell arteritis — vision loss risk

Symptoms

  • Bilateral shoulder painSymmetric shoulder/upper arm pain
  • Bilateral hip girdle painHip and upper thigh pain
  • Morning stiffness >45 minSevere stiffness lasting >1 hour
  • Functional impairmentDifficulty raising arms, rising from chair
  • Constitutional symptomsLow-grade fever, weight loss, fatigue

How it is examined

  • Restricted shoulder/hip ROMDecreased active abduction/flexion (pain-limited)
  • Preserved muscle strengthStrength preserved on passive testing (not true weakness)
  • Elevated ESR ≥40 + CRPKey lab finding in PMR; ESR 50–100 common
  • Dramatic steroid responsePrednisolone 15 mg/day → response within 24–72 hours

Imaging

X-ray usually normal; used to exclude other arthritides.

  • Normal joints
  • No erosions
  • May show degenerative changes

US/MRI shows subacromial-subdeltoid bursitis, bicipital tenosynovitis, trochanteric bursitis.

  • Subacromial-subdeltoid bursitis
  • Bicipital tenosynovitis
  • Hip synovitis
  • Trochanteric bursitis

Non-surgical care

  • Low-dose corticosteroidsPrednisolone 15 mg/day, gradual taper over 1–2 years
  • Methotrexate (steroid-sparing)Add for relapse or steroid intolerance
  • Tocilizumab (IL-6 inhibitor)Consider for refractory/relapsing PMR
  • Osteoporosis prophylaxisCalcium, vitamin D, bisphosphonates (for chronic steroid use)

Conservative options are generally tried first. Medications listed here can have side effects — discuss them with your prescriber.

When surgery is considered

No surgical indication

Procedures that may be discussed

  • Pharmacologic management only

Outlook

Most achieve remission within 1–2 years; 30–50% relapse. Watch for GCA complication.

Self-care notes by email

Occasional exercise, nutrition and recovery guides. No spam; unsubscribe anytime.

Privacy policy